{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:03:13Z","timestamp":1784203393878,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,16]]},"DOI":"10.7759\/cureus.112770","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:04:01Z","timestamp":1784199841000},"source":"Crossref","is-referenced-by-count":0,"title":["From Carcinoid Syndrome to Carcinoid Heart Disease: The Cost of Delayed Cardiac Surveillance"],"prefix":"10.7759","author":[{"given":"Christos E","family":"Ballas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tourmousoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Arseniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofilos M","family":"Kolettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-17-6562","article-title":"Carcinoid heart disease: review of current knowledge","volume":"46","author":"Ram P","year":"2019","unstructured":"Ram P, Penalver JL, Lo KB, Rangaswami J, Pressman GS. Carcinoid heart disease: review of current knowledge. Tex Heart Inst J. 2019, 46:21-7. 10.14503\/THIJ-17-6562","journal-title":"Tex Heart Inst J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.4.790","article-title":"Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography","volume":"92","author":"Robiolio PA","year":"1995","unstructured":"Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease: correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation. 1995, 92:790-5. 10.1161\/01.cir.92.4.790","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","author":"Fox DJ","year":"2004","unstructured":"Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis, and management. Heart. 2004, 90:1224-8. 10.1136\/hrt.2004.040329","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller JE","year":"2003","unstructured":"M\u00f8ller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors associated with progression of carcinoid heart disease. N Engl J Med. 2003, 348:1005-15. 10.1056\/NEJMoa021451","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12947-023-00316-6","article-title":"Prevalence, one-year-incidence and predictors of carcinoid heart disease","volume":"21","author":"Mattig I","year":"2023","unstructured":"Mattig I, Franke MR, Pschowski R, Brand A, Stangl K, Knebel F, Dreger H. Prevalence, one-year-incidence and predictors of carcinoid heart disease. Cardiovasc Ultrasound. 2023, 21:18. 10.1186\/s12947-023-00316-6","journal-title":"Cardiovasc Ultrasound"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.12.030","article-title":"Cardiac imaging in carcinoid heart disease","volume":"14","author":"Baron T","year":"2021","unstructured":"Baron T, Bergsten J, Alb\u00e5ge A, Lundin L, S\u00f6rensen J, \u00d6berg K, Flachskampf FA. Cardiac imaging in carcinoid heart disease. JACC Cardiovasc Imaging. 2021, 14:2240-53. 10.1016\/j.jcmg.2020.12.030","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka PA","year":"1993","unstructured":"Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. 1993, 87:1188-96. 10.1161\/01.cir.87.4.1188","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"M\u00f8ller JE","year":"2005","unstructured":"M\u00f8ller JE, Pellikka PA, Bernheim AM, Schaff HV, Rubin J, Connolly HM. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation. 2005, 112:3320-7. 10.1161\/CIRCULATIONAHA.105.553750","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for carcinoid heart disease","volume":"158","author":"Nguyen A","year":"2019","unstructured":"Nguyen A, Schaff HV, Abel MD, Luis SA, Lahr BD, Halfdanarson TR, Connolly HM. Improving outcome of valve replacement for carcinoid heart disease. J Thorac Cardiovasc Surg. 2019, 158:99-107.e2. 10.1016\/j.jtcvs.2018.09.025","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg S","year":"2022","unstructured":"Grozinsky-Glasberg S, Davar J, Hofland J, et al.. European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease. J Neuroendocrinol. 2022, 34:e13146. 10.1111\/jne.13146","journal-title":"J Neuroendocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/510223-from-carcinoid-syndrome-to-carcinoid-heart-disease-the-cost-of-delayed-cardiac-surveillance","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:04:01Z","timestamp":1784199841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/510223-from-carcinoid-syndrome-to-carcinoid-heart-disease-the-cost-of-delayed-cardiac-surveillance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.112770","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}